Contracts and Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member’s name and school(s) appointments at The University of Texas Health Science Center at Houston, contracting agency, contract amount and title.

New

Ben J. Barnett, Medical School (MS), A Randomized, Controlled, Partially Blinded Phase IIB Dose-Finding Trial of TMC125, in HIV-1 Infected Subjects with Documented Genotypic Evidence of Resistance to Currently Available NNRTIs and with at Least Three Primary PI Mutations, Tibotec Pharmaceuticals, $40,398.

Charles E. Begley, School of Public Health (SPH), Houston Safety Net Hospitals Emergency Department Use Study, Harris County Hospital District, $20,000.

Elmer V. Bernstam, School of Health Information Sciences and MS, Medical Letter Content for Decision Support at the Point of Care, Medical Letter Inc., $67,512.

Theresa L. Byrd, SPH, Understanding Health Resources in Schools, Texas Tech University Health Sciences Center, $21,000.

Margaret O. Caughy, SPH, Mother-Infant Conflict and Problem Behavior Development, National Institutes of Health (NIH), National Institute of Mental Health (NIMH), $93,375.

Stephen P. Daiger, SPH and Graduate School of Biomedical Sciences (GSBS), Microarray Identification of Mutations Causing Retinitis Pigmentosa, Gustavus and Louise Pfeiffer Research Foundation, $71,688.

Peter J. Davies, Health Science Center and GSBS, A Novel Endometrial Cancer Chemoprevention Strategy for Obese, Insulin- Resistant Women – An At-Risk Population, The University of Texas M. D. Anderson Cancer Center, $117,357.

Carlos A. Dumas, MS, Horizons in Family Medicine, Glaxo Smith Kline, $2,500.

Herbert L. DuPont, SPH and GSBS, Rifaximin in Standard Three-Day Dosing with and Without the Antimotility Drug Loperamide, Salix Pharmaceuticals, $737,100.

Danielle A. Garsin, MS and GSBS, C. Elegans as a Model Host for Understanding Innate Immune Response to Infectious Disease, Ellison Medical Foundation, $200,000.

Adelaide A. Hebert, MS, Safety and Efficacy of Imiquimod Cream 5%, 3M Pharmaceuticals, $81,100.

Barry D. Kahan, MS and GSBS, RAD001/Solid Organ Transplant, Novartis Pharmaceuticals Corp., $20,479.

Samia N. Khalil, MS, Comparison of the Safety and Efficacy of Patient Controlled Analgesia Delivered by HC, Ortho McNeil Pharmaceutical Inc., $87,075.

Nobuhide Kobori, MS,Working Memory Deficits Following Brain Trauma – Mechanisms of Working Memory Deficits, The Institute for Rehabilitation and Research, $109,090.

David S. Loose, MS and GSBS, Molecular Progression of Endometrial Cancer, UT M. D. Anderson Cancer Center, $190,922; and Core C: Biomarkers Core, UT M. D. Anderson Cancer Center, $173,019.

Emil Martin, MS, Structural Aspects of Soluble Guanylyl Cylase Activation, American Heart Association, Texas, $124,000.

Patricia D. Mullen, SPH, Project Choices – Preventing Alcohol-Exposed Pregnancies Among High Risk Women in Special Settings, Batelle Memorial Institute, $15,022.

Paula N. O’Neill, Dental Branch (DB), Achieving Diversity in Dentistry and Medicine, American Medical Student Association Foundation, $9,882.

Luis Ostrosky-Zeichner, MS, A Phase III, Randomized, Double-Blind, Comparative Study of Micafungin (FK463) Versus Caspofungin as an Antifungal Treatment in Patients with Invasive Candidiasis or Candidemia, Fujisawa Healthcare Inc., $143,000.

John Reveille, MS and GSBS, Phase III Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Active Ankylosing Spondylitis, Abbott Laboratories, $90,654.

Jan Risser, SPH, Epidemiology Needs Assessment, Texas Department of Health, $79,993.

Robert E. Roberts, SPH, Multi-Site Longitudinal Analysis of Psychiatric Risk of Substance Use Disorders, Duke University Medical Center, $44,457.

Faun G. Ryser, School of Nursing, Consortium to Advance Nursing Diversity and Opportunity (CANDO), Health Resources and Services Administration, $282,277.

Anne B. Sereno, MS and GSBS, The Neurobiology of Social Visual Pursuit: Implications for Autism, National Alliance for Autism Research, $120,000.

Stanislaw Stepkowski, MS and GSBS, Deletion of T and B Cells to Induce Tolerance, NIH, National Institute of Allergy and Infectious Diseases, $1,363,750.

Rita D. Swinford, MS, Study of the Pharmacokinetics of Sirolimus Administered Orally to Stable Renal Transplant, Wyeth Pharmaceuticals, $18,000.

Peter Szmuk, MS, An Efficacy Evaluation Supporting the Algorithm and System Validation/Verification Development of the T-Line® Tensymeter (Continuous Non-Invasive Blood Pressure Monitoring Device) via Direct Comparison to Data Obtained from Either an Indwelling Radial Artery Catheter (A-Line) or Intermittent Comparison to Data Obtained from an Automatic Blood Pressure Cuff (NIBP), Tensys Medical Inc., $66,950.

Jerry S.Wolinsky, A Randomized, Double-Blind, Placebo-Controlled, Parallel Groups Study to Assess the Effects of L-000, Merck & Co. Inc., $804,735.

Renewal

Terry J. Crow, MS, Analysis of Motor Systems Supporting Pavlovian Conditioning, NIH, NIMH, $1,485,000.

Lenard M. Lichtenberger, MS and GSBS, GI Safety and Therapeutics of Oil-Based PC-NSAIDS, PLX Pharma Inc., $166,665.

Chunlin Qin, DB, Studies of Proteins Involved in Dentinogenesis, NIH, National Institute of Dental and Craniofacial Research, $1,485,000.

Ann-Bin Shyu, MS and GSBS, Messenger RNA Decay of Immediate Early Genes, NIH, National Institute of General Medical Sciences, $2,129,541.

Melvin Neal Waxham, MS and GSBS, Training in Neuroscience, NIH, National Institute of Neurological Disorders and Stroke, $599,635.